Finch Therapeutics Group, Inc.
FNCH
$13.25
-$0.20-1.49%
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 30.45% | 93.78% | 88.74% | 94.02% | 69.38% |
| Total Depreciation and Amortization | -22.81% | -96.85% | -96.88% | -96.30% | -95.82% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 302.74% | -98.72% | -99.21% | -94.91% | -111.24% |
| Change in Net Operating Assets | 73.23% | -185.66% | -149.34% | -208.94% | -167.98% |
| Cash from Operations | 48.39% | 67.40% | 74.03% | 72.45% | 42.19% |
| Capital Expenditure | -- | -- | 127.45% | 100.00% | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | 200.00% | 106.10% | 242.06% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 100.00% | 100.00% | 100.00% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 103.03% |
| Cash from Financing | -- | -- | -100.00% | -100.00% | -99.97% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 40.05% | 85.24% | 74.39% | 72.96% | -302.60% |
